Our research shows the transformative effect that alemtuzumab can have for people with MS.
Patients who continue to show disease activity while on their initial therapy are especially difficult to treat.
Now, we have shown that alemtuzumab works where first-line drugs have already failed.
It not only reduces the chances of disability associated with MS but may even result in long-term clinical improvements.
More top news
Sheffield United are close to agreeing a deal to re-sign striker Ched Evans from Chesterfield, ITV News understands.
Cold and unsettled tomorrow with a chilly wind.
Police have released CCTV as they appeal for help in finding a 27-year-old trainee nurse who has been missing since last Thurday.